Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kunihiko Kameda"'
Autor:
Hirotsugu Ono, Hiroyuki Hanada, Toshiro Matsunaga, Tomohiro Osanai, Jin Yokoyama, Kunihiko Kameda, Naoki Abe, Takayuki Fujiwara, Ken Okumura, Takumi Higuma
Publikováno v:
Heart and Vessels. 22:303-309
Nicorandil, a hybrid KATP channel opener and nicotinamide nitrate, reduces no-reflow phenomenon and improves cardiac function in patients with acute myocardial infarction (AMI). We reported that nicorandil suppresses radical formation in patients wit
Autor:
Kozo Fukui, Toshiro Matsunaga, Tomohiro Osanai, Hiroyuki Hanada, Naoki Abe, Ken Okumura, Kunihiko Kameda, Ikuo Fukuda, Takayuki Fujiwara
Publikováno v:
Circulation Journal. 70:673-678
Background In an animal model of acute myocardial infarction (AMI), deletion of matrix metalloproteinase (MMP)-9 results in suppression of the development of cardiac rupture. The present study sought to clarify how myocardial MMP-9 activity is relate
Autor:
Toshiro Matsunaga, Tomohiro Osanai, Ken Okumura, Hirotsugu Ono, Hiroshi Ishizaka, Naoki Abe, Masayuki Saitoh, Kozo Fukui, Hiroyuki Hanada, Kunihiko Kameda, Ikuo Fukuda
Publikováno v:
European Heart Journal. 24:2180-2185
Aim Oxidative stress is implicated in the progression of heart failure, and matrix metalloproteinase (MMP) activity is increased in patients with congestive heart failure. We examined the role of oxidative stress on MMP activity in humans. Methods an
Autor:
Kunihiko Yomogida, Ken Okumura, Shingen Owada, Naoki Abe, Daisuke Horiuchi, Osamu Suzuki, Kouichi Oikawa, Hirofumi Tomita, Kunihiko Kameda, Shin Nakamura, Takashi Komatsu
Publikováno v:
Japanese Journal of Electrocardiology. 23:200-206
Autor:
Takeshi Kudo, Tomohiro Osanai, Ken Okumura, Takumi Higuma, Naoyuki Suto, Takeshi Kato, Yoshiki Hoshi, Yoichi Inokubo, Norio Fujita, Koichi Oikawa, Kunihiko Kameda, Atsushi Konta, Yasuhiro Mori, Takeru Yamamoto
Publikováno v:
Journal of cardiology. 56(3)
We compared the efficacy of once-daily administration of nifedipine CR 40 mg (N) with that of twice-daily diltiazem R 100mg (D) in patients with vasospastic angina (VSA) registered in 8 cardiovascular institutes in Aomori Prefecture.VSA was diagnosed
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 34(10)
A 58-year-old male with advanced gastric cancer underwent a total gastrectomy after neoadjuvant chemotherapy with paclitaxel and cisplatin. The combination chemotherapy was resumed postoperatively as adjuvant chemotherapy. Although no recurrence was
Autor:
Naoki Abe, Toshiro Matsunaga, Kunihiko Kameda, Hirofumi Tomita, Tomohiro Osanai, Kozo Fukui, Ikuo Fukuda, Ken Okumura
Publikováno v:
Circulation. 116
Insulin-like growth factor (IGF)-1 is a potent mitogen and is said to enhance ventricular hypertrophy. IGF-1 is present as an IGF-1-IGF binding protein-3 (IGFBP-3) complex, and its free form shows bioactivity. Recently, the matrix metalloproteinases
Autor:
Kunihiko, Kameda, Toshiro, Matsunaga, Naoki, Abe, Takayuki, Fujiwara, Hiroyuki, Hanada, Kozo, Fukui, Ikuo, Fukuda, Tomohiro, Osanai, Ken, Okumura
Publikováno v:
Circulation journal : official journal of the Japanese Circulation Society. 70(6)
In an animal model of acute myocardial infarction (AMI), deletion of matrix metalloproteinase (MMP)-9 results in suppression of the development of cardiac rupture. The present study sought to clarify how myocardial MMP-9 activity is related to the pa
Autor:
Toshiro Matsunaga, Naoki Abe, Tomohiro Osanai, Kunihiko Kameda, Ken Okumura, Takayuki Fujiwara
Publikováno v:
Life sciences. 78(9)
Extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase (MMP)-9 were reported to be expressed at the macrophage-rich area in human coronary atherosclerotic plaque. We examined whether C-reactive protein (CRP) activates m
Autor:
Takashi, Komatsu, Kunihiko, Yomogida, Shin, Nakamura, Osamu, Suzuki, Daisuke, Horiuchi, Kunihiko, Kameda, Hirofumi, Tomita, Naoki, Abe, Shingen, Owada, Koichi, Oikawa, Ken, Okumura
Publikováno v:
Journal of cardiology. 42(3)
The relationship between the duration of arrhythmia and the subsequent long-term efficacy of disopyramide in preventing atrial fibrillation was investigated in patients with symptomatic paroxysmal and persistent atrial fibrillation.A total of 60 pati